Besides lung cancer, ESCC, melanoma, GC and breast cancer, RICTOR overexpression was also reported in glioblastoma [32, 33], hepatocellular carcinomas [34] and pancreatic ductal adenocarcinoma (PDAC) [35]. Here, RICTOR is linked to esophageal squamous cell carcinoma.